Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Non Operating Investment Income: 2010-2011

Historic Non Operating Investment Income for Altimmune (ALT) over the last 2 years, with Dec 2011 value amounting to $7.1 million.

  • Altimmune's Non Operating Investment Income rose 19.70% to $823,809 in Q2 2012 from the same period last year, while for Jun 2012 it was $3.8 million, marking a year-over-year increase of 247.20%. This contributed to the annual value of $7.1 million for FY2011, which is 230.92% up from last year.
  • As of FY2011, Altimmune's Non Operating Investment Income stood at $7.1 million, which was up 230.92% from -$5.5 million recorded in FY2010.
  • In the past 5 years, Altimmune's Non Operating Investment Income registered a high of $7.1 million during FY2011, and its lowest value of -$5.5 million during FY2010.
  • For the 2-year period, Altimmune's Non Operating Investment Income averaged around $843,716, with its median value being $843,716 (2010).
  • Data for Altimmune's Non Operating Investment Income shows a peak YoY spiked of 230.92% (in 2011) over the last 5 years.
  • Over the past 2 years, Altimmune's Non Operating Investment Income (Yearly) stood at -$5.5 million in 2010, then soared by 230.92% to $7.1 million in 2011.